Search details
1.
Long-term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high-risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party-EBMT.
Br J Haematol
; 196(4): 1018-1030, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34750806
2.
Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma.
Biol Blood Marrow Transplant
; 22(10): 1808-1815, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27470290
3.
Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation.
Bone Marrow Transplant
; 55(2): 419-430, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31551517
4.
Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation.
Bone Marrow Transplant
; 52(3): 438-444, 2017 Mar.
Article
in English
| MEDLINE | ID: mdl-27819684
5.
Potential protective effect of Helicobacter pylori on the development of gastrointestinal GvHD.
Bone Marrow Transplant
; 51(6): 819-24, 2016 Jun.
Article
in English
| MEDLINE | ID: mdl-26950379
6.
Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience.
Bone Marrow Transplant
; 51(10): 1307-1312, 2016 Oct.
Article
in English
| MEDLINE | ID: mdl-27159177
7.
Influence of donor age in allogeneic stem cell transplant outcome in acute myeloid leukemia and myelodisplastic syndrome.
Leuk Res
; 39(8): 828-34, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26009156
8.
GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT.
Bone Marrow Transplant
; 50(1): 121-6, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25310306
9.
In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone.
Leukemia
; 29(3): 705-14, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25102946
10.
Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma.
Bone Marrow Transplant
; 50(6): 802-7, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25798673
11.
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT.
Bone Marrow Transplant
; 49(9): 1170-5, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-24978140
12.
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.
Bone Marrow Transplant
; 49(5): 684-90, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24566710
13.
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Bone Marrow Transplant
; 49(3): 389-96, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24419525
14.
Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation.
Bone Marrow Transplant
; 54(5): 757-761, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30356164
15.
Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning.
Bone Marrow Transplant
; 47(10): 1343-9, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22388280
16.
SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status.
Leukemia
; 26(12): 2521-9, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-22565645
17.
Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients.
Leukemia
; 26(8): 1862-9, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22333880
18.
GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study.
Bone Marrow Transplant
; 51(11): 1524-1526, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27295268
19.
Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma.
Leukemia
; 25(4): 697-706, 2011 Apr.
Article
in English
| MEDLINE | ID: mdl-21252988
Results
1 -
19
de 19
1
Next >
>>